VECTIVBIO
LIVE

Serial Number

88468906

Owner

Dikean Management AG

Attorney

Frances M. Jagla

Filing Date

Jun 11, 2019

Add to watchlist:

No watchlists yet
View on USPTO

VECTIVBIO Trademark

Serial Number: 88468906 • Registration: 6285701

VECTIVBIO is a trademark filed by Dikean Management AG on June 11, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Dikean Management AG (2 trademarks)

c/o Therachon AG
Basel 4051 , CH

Entity Type: 03

VECTIVBIO AG

Aeschenvorstadt 36
BASEL 4051 , CH

Entity Type: 03

Trademark Details

Filing Date

June 11, 2019

Registration Date

March 9, 2021

Published for Opposition

December 22, 2020

Goods & Services

Consulting on medicines, namely, medical and pharmaceutical consultation

Plant extracts for medical and pharmaceutical research purposes

Scientific research, technological development of new products for others; medical research; scientific and industrial research in the fields of biotechnology, biology, rare diseases and conditions, genetic conditions and treatments of rare diseases and conditions; industrial research in the field of biomedical and phytopharmaceutical engineering; pharmaceutical laboratory services; pharmaceutical research and development; scientific services, namely, development of drugs, active agents and vaccines; scientific services, namely, development of food supplements; development of pharmaceutical preparations and medicines; development of pharmaceuticals and medicines and plant extracts for use in pharmaceutical preparations and medicines

Medical diagnostic apparatus for detecting diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; Surgical apparatus and instruments for medical or veterinary use; Surgical and medical apparatus and instruments for use in orthopedic surgery; Medical and surgical apparatus and instruments, namely, orthopedic apparatus and instruments for diagnostic and therapeutic use; Medical and surgical apparatus, medical instruments for use in treating genetic conditions, rare diseases and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; orthopaedic articles, namely, orthopedic devices for diagnostic and therapeutic use; orthopaedic articles, namely, vertebral orthopedic apparatus; suture materials; therapeutic and assistive devices adapted for the disabled, namely, motion sensing apparatus and assisted machines for the rehabilitation of hands and wrists, feet and ankles, knees, spine affected by neuromuscular diseases, disorders, or injuries for home or clinical use; massage apparatus; Medical and surgical apparatus and instruments, namely, orthopedic fixation device used in orthopedic transplant and/or implant surgery

Nutritional additives for medical purposes in the nature of natural food extracts derived from herbs, fruits, spices, vegetables, algae, fungi; nutritional food additives for medical purposes in the nature of natural food extracts derived from meat, fish, poultry and game, meat extracts, fruit and canned vegetables, dried and cooked, jellies, jams, compotes, eggs, milk and milk products, edible oils and fats; phytopharmaceuticals for the treatment of autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; plant extracts for medical purposes; pharmaceutical for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; sanitary preparations for medical use; dietetic food, namely, herbs, fruits, spices, vegetables, algae, fungi; dietetic food, namely, food for babies; adjuvants for medical purposes; amino acids for medical purposes; anaesthetics; analgesics; vermifuges; antibiotics; biological preparations for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; chemical active components for medical use, namely, chemical preparations for treating genetic conditions, rare diseases and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; ferments for pharmaceutical purposes; hormones for medical purposes; medical infusions for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; medicines for the treatment of gum disease, caries, toothache and wound healing of the gums; medicines for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; radiological contrast substances for medical purposes; steroids

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 9, 2026 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 7, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 7, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 7, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 7, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 7, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 7, 2023 COAR
REGISTERED-PRINCIPAL REGISTER
Mar 9, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 22, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 22, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 2, 2020 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Nov 12, 2020 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Nov 6, 2020 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2020 CNSA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 28, 2020 ASGN
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 27, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 13, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 13, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 13, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 16, 2020 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 23, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 23, 2020 GNSL
SUSPENSION LETTER WRITTEN
Mar 23, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 10, 2019 GNRN
NON-FINAL ACTION E-MAILED
Sep 10, 2019 GNRT
NON-FINAL ACTION WRITTEN
Sep 10, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 3, 2019 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2019 CRFA
ASSIGNED TO LIE
Jun 25, 2019 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2019 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 19, 2019 PARI
NEW APPLICATION ENTERED
Jun 14, 2019 NWAP